Vitamin D and sepsis: From associations to causal connections

Inflammation and Allergy - Drug Targets

Volumn 12, Issue 4, 2013, Pages 246-252

  Kempker, Jordan A ^a   Martin, Greg S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Critical illness; Ecology; Epidemiology; Immunology; Immunonutrition; Infection; Nutrition; Sepsis; Vitamin d

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; VITAMIN D;

DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFLUENZA; MORTALITY; NONHUMAN; NUTRITION; PREVALENCE; RACE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SEASONAL VARIATION; SEPSIS; SKIN PIGMENTATION; ULTRAVIOLET RADIATION;

DIETARY SUPPLEMENTS; HUMANS; SEPSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84882806865     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/18715281113129990048     Document Type: Review

References (93)

1. Dellinger, R.P.; Levy, M.M.; Carlet, J.M.; Bion, J.; Parker, M.M.; Jaeschke, R.; Reinhart, K.; Angus, D.C.; Brun-Buisson, C.; Beale, R.; Calandra, T.; Dhainaut, J.F.; Gerlach, H.; Harvey, M.; Marini, J.J.; Marshall, J.; Ranieri, M.; Ramsay, G.; Sevransky, J.; Thompson, B.T.; Townsend, S.; Vender, J.S.; Zimmerman, J.L.; Vincent, J.L. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med., 2008, 36(1), 296-327.
2. Holick, M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr., 1995, 61(3 Suppl), 638S-645S.
3. Kimlin, M.G. Geographic location and vitamin D synthesis. Mol. Aspects Med., 2008, 29(6), 453-461.
4. Shoben, A.B.; Kestenbaum, B.; Levin, G.; Hoofnagle, A.N.; Psaty, B.M.; Siscovick, D.S.; de Boer, I.H. Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. Am. J. Epidemiol., 2011, 174(12), 1363-1372.
5. Macdonald, H.M.; Mavroeidi, A.; Fraser, W.D.; Darling, A.L.; Black, A.J.; Aucott, L.; O'Neill, F.; Hart, K.; Berry, J.L.; Lanham-New, S.A.; Reid, D.M. Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos. Int., 2011, 22(9), 2461-2472.
6. Karohl, C.; Su, S.; Kumari, M.; Tangpricha, V.; Veledar, E.; Vaccarino, V.; Raggi, P. Heritability and seasonal variability of vitamin D concentrations in male twins. Am. J. Clin. Nutr., 2010, 92(6), 1393-1398.
7. Pettifor, J.M.; Moodley, G.P.; Hough, F.S.; Koch, H.; Chen, T.; Lu, Z.; Holick, M.F. The effect of season and latitude on in vitro vitamin D formation by sunlight in South Africa. S. Afr. Med. J., 1996, 86(10), 1270-1272.
8. Webb, A.R.; Kline, L.; Holick, M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab., 1988, 67(2), 373-378.
9. Danai, P.A.; Sinha, S.; Moss, M.; Haber, M.J.; Martin, G.S. Seasonal variation in the epidemiology of sepsis. Crit. Care Med., 2007, 35(2), 410-415.
10. Dowell, S.F. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg. Infect. Dis., 2001, 7(3), 369-374.
11. Hope-Simpson RE The role of season in the epidemiology of influenza. J. Hyg. (Lond), 1981, 86(1), 35-47.
12. Juzeniene, A.; Ma, L.W.; Kwitniewski, M.; Polev, G.A.; Lagunova, Z.; Dahlback, A.; Moan, J. The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. Int. J. Infect. Dis., 2010, 14(12), e1099-1105.
13. Korthals Altes, H.; Kremer, K.; Erkens, C.; van Soolingen, D.; Wallinga, J. Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency? Int. J. Tuberc. Lung Dis., 2012, 16(5), 639-644.
14. Parrinello, C.M.; Crossa, A.; Harris, T.G. Seasonality of tuberculosis in New York City, 1990-2007. Int. J. Tuberc. Lung Dis., 2012, 16(1), 32-37.
15. Maclachlan, J.H.; Lavender, C.J.; Cowie, B.C. Effect of latitude on seasonality of tuberculosis, Australia, 2002-2011. Emerg. Infect. Dis., 2012, 18(11), 1879-1881.
16. Martineau, A.R.; Nhamoyebonde, S.; Oni, T.; Rangaka, M.X.; Marais, S.; Bangani, N.; Tsekela, R.; Bashe, L.; de Azevedo, V.; Caldwell, J.; Venton, T.R.; Timms, P.M.; Wilkinson, K.A.; Wilkinson, R.J. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc. Natl. Acad Sci. U S A, 2011, 108(47), 19013-19017.
17. Khoo, A.L.; Chai, L.Y.; Koenen, H.J.; Sweep, F.C.; Joosten, I.; Netea, M.G.; van der Ven, A.J. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin. Exp. Immunol., 2011, 164(1), 72-79.
18. Khoo, A.L.; Chai, L.Y.; Koenen, H.J.; Kullberg, B.J.; Joosten, I.; van der Ven, A.J.; Netea, M.G. 1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses. J. Infect. Dis., 2011, 203(1), 122-130.
19. Khoo, A.L.; Koenen, H.J.; Chai, L.Y.; Sweep, F.C.; Netea, M.G.; van der Ven, A.J.; Joosten, I. Seasonal variation in vitamin D(3) levels is paralleled by changes in the peripheral blood human T cell compartment. PLoS One, 2012, 7(1), e29250.
20. Fioletov, V.E.; McArthur, L.J.; Mathews, T.W.; Marrett, L. Estimated ultraviolet exposure levels for a sufficient vitamin D status in North America. J. Photochem. Photobiol. B, 2010, 100(2), 57-66.
21. Kimlin, M.G.; Olds, W.J.; Moore, M.R. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J. Photochem. Photobiol. B, 2007, 86(3), 234-239.
22. Webb, A.R.; Pilbeam, C.; Hanafin, N, Holick, M.F. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am, J. Clin. Nutr., 1990, 51(6), 1075-1081.
23. Chen, T.C.; Chimeh, F.; Lu, Z.; Mathieu, J.; Person, K.S.; Zhang, A.; Kohn, N.; Martinello, S.; Berkowitz, R.; Holick, M.F. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem. Biophys., 2007, 460(2), 213-217.
24. Rockell, J.E.; Osteoporos. Int., 2008, 19(11), 1639-1642.
25. Looker, A.C.; Dawson-Hughes, B.; Calvo, M.S.; Gunter, E.W.; Sahyoun, N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone, 2002, 30(5), 771-777.
26. Barnato, A.E.; Alexander, S.L.; Linde-Zwirble, W.T.; Angus, D.C. Racial variation in the incidence.; care.; and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am. J. Respir. Crit. Care Med., 2008, 177(3), 279-284.
27. Esper, A.M.; Moss, M.; Lewis, C.A.; Nisbet, R.; Mannino, D.M.; Martin, G.S. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit. Care Med., 2006, 34(10), 2576-2582.
28. Martin, G.S.; Mannino, D.M.; Eaton, S.; Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med., 2003, 348(16), 1546-1554.
29. Mayr, F.B.; Yende, S.; Linde-Zwirble, W.T.; Peck-Palmer, O.M.; Barnato, A.E.; Weissfeld, L.A.; Angus, D.C. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA, 2010, 303(24), 2495-2503.
30. Richardus, J.H.; Kunst, A.E. Black-white differences in infectious disease mortality in the United States. Am. J. Public Health, 2001, 91(8), 1251-1253.
31. McQuillan, G.M.; Kruszon-Moran, D.; Kottiri, B.J.; Curtin, L.R.; Lucas, J.W.; Kington, R.S. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III.; 1988-1994. Am. J. Public Health, 2004, 94(11), 1952-1958.
32. Ginde, A.A.; Mansbach, J.M.; Camargo, C.A.; Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med., 2009, 169(4), 384-390.
33. Hewison, M. Antibacterial effects of vitamin D. Nat. Rev. Endocrinol., 2011, 7(8), 436.
34. Nijnik, A.; Hancock, R.E. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol., 2009, 16(1), 41-47.
35. Turner, J.; Cho, Y.; Dinh, N.N.; Waring, A.J.; Lehrer, R.I. Activities of LL-37.; a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother., 1998, 42(9), 2206-2214.
36. Bhan, I.; Camargo, C.A. Jr.; Wenger, J.; Ricciardi, C.; Ye, J.; Borregaard, N.; Thadhani, R. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J. Allergy Clin. Immunol., 2011, 127(5), 1302-1304+e1301.
37. Dixon, B.M.; Barker, T.; McKinnon, T.; Cuomo, J.; Frei, B.; Borregaard, N.; Gombart, A.F. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res. Notes, 2012, 5(1), 575.
38. Jeng, L.; Yamshchikov, A.V.; Judd, S.E.; Blumberg, H.M.; Martin, G.S.; Ziegler, T.R.; Tangpricha, V. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med., 2009, 728.
39. Strandberg, K.L.; Richards, S.M.; Gunn, J.S. Cathelicidin antimicrobial peptide expression is not induced or required for bacterial clearance during salmonella enterica infection of human monocyte-derived macrophages. Infect. Immun., 2012, 80(11), 3930-3938.
40. Leow, L.; Simpson, T.; Cursons, R.; Karalus, N.; Hancox, R.J. Vitamin D.; innate immunity and outcomes in community acquired pneumonia. Respirology, 2011, 16(4), 611-616.
41. Gombart, A.F.; Bhan, I.; Borregaard, N.; Tamez, H.; Camargo, C.A.; Jr.; Koeffler, H.P.; Thadhani, R. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin. Infect. Dis., 2009, 48(4), 418-424.
42. Nelson, C.D.; Reinhardt, T.A.; Beitz, D.C.; Lippolis, J.D. In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One, 2010, 5(11), e15469.
43. Hertting, O.; Holm, A.; Luthje, P.; Brauner, H.; Dyrdak, R.; Jonasson, A.F.; Wiklund, P.; Chromek, M.; Brauner, A. Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One, 2010, 5(12), e15580.
44. Yim, S.; Dhawan, P.; Ragunath, C.; Christakos, S.; Diamond, G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros., 2007, 6(6), 403-410.
45. Ryz, N.R.; Patterson, S.J.; Zhang, Y.; Ma, C.; Huang, T.; Bhinder, G.; Wu, X.; Chan, J.; Glesby, A.; Sham, H.P.; Dutz, J.P.; Levings, M.K.; Jacobson, K.; Vallance, B.A. Active vitamin D (1.;25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am. J. Physiol. Gastrointest. Liver Physiol., 2012, 303(12), G1299-1311.
46. Love, J.F.; Tran-Winkler, H.J.; Wessels, M.R. Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells. MBio, 2012, 3(5), pii: e00394-12.
47. Hansdottir, S.; Monick, M.M.; Lovan, N.; Powers, L.; Gerke, A.; Hunninghake, G.W. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J. Immunol., 2010, 184(2), 965-974.
48. Jeurissen, A.; Van Etten, E.; Overbergh, L.; Wuyts, G.; Heremans, H.; Matthys, P.; Ceuppens, J.L.; Mathieu, C.; Bossuyt, X. 1alpha,25-Dihydroxyvitamin D3 modulates the murine antibody response to pneumococcal capsular polysaccharide serotype 3 through IL-12. Eur. J. Immunol., 2005, 35(6), 1841-1848.
49. Roth, D.E.; Shah, R.; Black, R.E.; Baqui, A.H. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet; Bangladesh. Acta. Paediatr., 2010, 99(3), 389-393.
50. Mohamed, W.A.; Al-Shehri, M.A. Cord Blood 25-Hydroxyvitamin D Levels and the Risk of Acute Lower Respiratory Tract Infection in Early Childhood. J. Trop. Pediatr., 2013, 59(1), 29-35.
51. Karatekin, G.; Kaya, A.; Salihoglu, O.; Balci, H.; Nuhoglu, A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur. J. Clin. Nutr.; 2009, 63(4), 473-477.
52. Roth, D.E.; Jones, A.B.; Prosser, C.; Robinson, J.L.; Vohra, S. Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur. J. Clin. Nutr., 2009, 63(2), 297-299.
53. McNally, J.D.; Leis, K.; Matheson, L.A.; Karuananyake, C.; Sankaran, K.; Rosenberg, A.M. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr. Pulmonol., 2009, 44(10), 981-988.
54. Wayse, V.; Yousafzai, A.; Mogale, K.; Filteau, S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur. J. Clin. Nutr., 2004, 58(4), 563-567.
55. Banajeh, S.M. Nutritional rickets and vitamin D deficiency--association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr. Pulmonol., 2009, 44(12), 1207-1215.
56. Inamo, Y.; Hasegawa, M.; Saito, K.; Hayashi, R.; Ishikawa, T.; Yoshino, Y.; Hashimoto, K.; Fuchigami, T. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatr. Int., 2011, 53(2), 199-201.
57. Roth, D.E.; Jones, A.B.; Prosser, C.; Robinson, J.L.; Vohra, S. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J. Infect. Dis., 2008, 197(5), 676-680.
58. Sabetta, J.R.; DePetrillo, P.; Cipriani, R.J.; Smardin, J.; Burns, L.A.; Landry, M.L. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One, 2010, 5(6), e11088.
59. Remmelts, H.H.; van de Garde, E.M.; Meijvis, S.C.; Peelen, E.L.; Damoiseaux, J.G.; Grutters, J.C.; Biesma, D.H.; Bos, W.J.; Rijkers, G.T. Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin. Infect. Dis., 2012, 55(11), 1488-1494.
60. Manaseki-Holland, S.; Qader, G.; Isaq Masher, M.; Bruce, J.; Zulf Mughal, M.; Chandramohan, D.; Walraven, G. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop. Med. Int. Health, 2010, 15(10), 1148-1155.
61. Choudhary, N.; Gupta, P. Vitamin D supplementation for severe pneumonia--a randomized controlled trial. Indian Pediatr., 2012, 49(6), 449-454.
62. Manaseki-Holland, S.; Maroof, Z.; Bruce, J.; Mughal, M.Z.; Masher, M.I.; Bhutta, Z.A.; Walraven, G.; Chandramohan, D. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet, 2012, 379(9824), 1419-1427.
63. Urashima, M.; Segawa, T.; Okazaki, M.; Kurihara, M.; Wada, Y.; Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr., 2010, 91(5), 1255-1260.
64. Laaksi, I.; Ruohola, J.P.; Mattila, V.; Auvinen, A.; Ylikomi, T.; Pihlajamaki, H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized.; double-blinded trial among young Finnish men. J. Infect. Dis., 2010, 202(5), 809-814.
65. Li-Ng, M.; Aloia, J.F.; Pollack, S.; Cunha, B.A.; Mikhail, M.; Yeh, J.; Berbari, N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect., 2009, 137(10), 1396-1404.
66. Murdoch, D.R.; Slow, S.; Chambers, S.T.; Jennings, L.C.; Stewart, A.W.; Priest, P.C.; Florkowski, C.M.; Livesey, J.H.; Camargo, C.A.; Scragg, R. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA, 2012, 308(13), 1333-1339.
67. Fabri, M.; Stenger, S.; Shin, D.M.; Yuk, J.M.; Liu, P.T.; Realegeno, S.; Lee, H.M.; Krutzik, S.R.; Schenk, M.; Sieling, P.A.; Teles, R.; Montoya, D.; Iyer, S.S.; Bruns, H.; Lewinsohn, D.M.; Hollis, B.W.; Hewison, M.; Adams, J.S.; Steinmeyer, A.; Zugel, U.; Cheng, G.; Jo, E.K.; Bloom, B.R.; Modlin, R.L. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci. Transl. Med., 2011, 3(104), 104ra102.
68. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C.; Kamen, D.L.; Wagner, M.; Bals, R.; Steinmeyer, A.; Zugel, U.; Gallo, R.L.; Eisenberg, D.; Hewison, M.; Hollis, B.W.; Adams, J.S.; Bloom, B.R.; Modlin, R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006, 311(5768), 1770-1773.
69. Martineau, A.R.; Wilkinson, K.A.; Newton, S.M.; Floto, R.A.; Norman, A.W.; Skolimowska, K.; Davidson, R.N.; Sorensen, O.E.; Kampmann, B.; Griffiths, C.J.; Wilkinson, R.J. IFN-gamma-and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol., 2007, 178(11), 7190-7198.
70. Prabhu Anand, S.; Selvaraj, P.; Narayanan, P.R. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine, 2009, 45(2), 105-110.
71. Martineau, A.R.; Timms, P.M.; Bothamley, G.H.; Hanifa, Y.; Islam, K.; Claxton, A.P.; Packe, G.E.; Moore-Gillon, J.C.; Darmalingam, M.; Davidson, R.N.; Milburn, H.J.; Baker, L.V.; Barker, R.D.; Woodward, N.J.; Venton, T.R.; Barnes, K.E.; Mullett, C.J.; Coussens, A.K.; Rutterford, C.M.; Mein, C.A.; Davies, G.R.; Wilkinson, R.J.; Nikolayevskyy, V.; Drobniewski, F.A.; Eldridge, S.M.; Griffiths, C.J. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet, 2011, 377(9761), 242-250.
72. Coussens, A.K.; Wilkinson, R.J.; Hanifa, Y.; Nikolayevskyy, V.; Elkington, P.T.; Islam, K.; Timms, P.M.; Venton, T.R.; Bothamley, G.H.; Packe, G.E.; Darmalingam, M.; Davidson, R.N.; Milburn, H.J.; Baker, L.V.; Barker, R.D.; Mein, C.A.; Bhaw-Rosun, L.; Nuamah, R.; Young, D.B.; Drobniewski, F.A.; Griffiths, C.J.; Martineau, A.R. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc. Natl. Acad Sci. U S A, 2012, 109(38), 15449-15454.
73. Gynther, P.; Toropainen, S.; Matilainen, J.M.; Seuter, S.; Carlberg, C.; Vaisanen S Mechanism of 1alpha.;25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim. Biophys. Acta, 2011, 1813(5), 810-818.
74. Matilainen, J.M.; Husso, T.; Toropainen, S.; Seuter, S.; Turunen, M.P.; Gynther, P.; Yla-Herttuala, S.; Carlberg, C.; Vaisanen, S. Primary effect of 1alpha.;25(OH)(2)D(3) on IL-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta, 2010, 1803(11), 1276-1286.
75. Matilainen, J.M.; Rasanen, A.; Gynther, P.; Vaisanen, S. The genes encoding cytokines IL-2.; IL-10 and IL-12B are primary 1alpha.;25(OH)2D3 target genes. J. Steroid Biochem. Mol. Biol., 2010, 121(1-2), 142-145.
76. Sadeghi, K.; Wessner, B.; Laggner, U.; Ploder, M.; Tamandl, D.; Friedl, J.; Zugel, U.; Steinmeyer, A.; Pollak, A.; Roth, E.; Boltz-Nitulescu, G.; Spittler, A Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol., 2006, 36(2), 361-370.
77. Zhang, Y.; Leung, D.Y.; Richers, B.N.; Liu, Y.; Remigio, L.K.; Riches, D.W.; Goleva, E. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J. Immunol., 2012, 188(5), 2127-2135.
78. Equils, O.; Naiki, Y.; Shapiro, A.M.; Michelsen, K.; Lu, D.; Adams, J.; Jordan, S 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin. Exp. Immunol., 2006, 143(1), 58-64.
79. Horiuchi, H.; Nagata, I.; Komoriya, K.Protective effect of vitamin D3 analogues on endotoxin shock in mice. Agents Actions, 1991, 33(3-4), 343-348.
80. Moller, S.; Laigaard, F.; Olgaard, K.; Hemmingsen, C. Effect of 1.;25-dihydroxy-vitamin D3 in experimental sepsis. Int. J. Med. Sci., 2007, 4(4), 190-195.
81. Cecchi, A.; Bonizzoli, M.; Douar, S.; Mangini, M.; Paladini, S.; Gazzini, B.; Degl'innocenti, S.; Linden, M.; Zagli, G.; Peris, A. Vitamin D deficiency in septic patients at ICU admission is not a mortality predictor. Minerva Anestesiol, 2011, 77(12), 1184-1189.
82. Ginde, A.A.; Camargo, C.A. Jr.; Shapiro, N.I. Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. Acad Emerg. Med.; 2011, 18(5), 551-554.
83. National Library of Medicine. ClinicalTrials.gov. http://www.clinicaltrials.gov/ct2/show/NCT0168944 [Accessed January 31, 2013]
84. National Library of Medicine. ClinicalTrials.gov. http://www.clinicaltrials.gov/ct2/show/NCT01600430 [Accessed January 31, 2013]
85. Lee, P.; Eisman, J.A.; Center J.R. Vitamin D deficiency in critically ill patients. N. Engl. J. Med., 2009, 360(18), 1912-1914.
86. Lucidarme, O.; Messai, E.; Mazzoni, T.; Arcade, M.; du Cheyron, D. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med., 2010, 36(9), 1609-1611.
87. Nair, P. Myburgh, J.; Eisman, J.A.; Center, J.R. Significant perturbation of vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients. Intensive Care Med., 2013, 39(2), 267-274.
88. Braun, A.B.; Litonjua, A.A.; Moromizato, T.; Gibbons, F.K.; Giovannucci, E.; Christopher, K.B. Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill. Crit Care Med., 2012, 40(12), 3170-3179.
89. Braun, A.B.; Gibbons, F.K.; Litonjua, A.A.; Giovannucci, E.; Christopher, K.B. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit. Care Med., 2012, 40(1), 63-72.
90. Rippel, C.; South, M.; Butt, W.W.; Shekerdemian, L.S. Vitamin D status in critically ill children. Intensive Care Med., 2012, 38(12), 2055-2062.
91. Venkatram, S.; Chilimuri, S.; Adrish, M.; Salako, A.; Patel, M.; Diaz-Fuentes, G. Vitamin D deficiency as associated with mortality in the medical intensive care unit. Crit. Care, 2011, 15(6), R292.
92. McKinney, J.D.; Bailey, B.A.; Garrett, L.H.; Peiris, P.; Manning, T.; Peiris, A.N. Relationship between vitamin D status and ICU outcomes in veterans. J. Am. Med. Dir. Assoc, 2011, 12(3), 208-211.
93. National Library of Medicine. ClinicalTrials.gov. http://www.clinicaltrials.gov/ct2/show/NCT01130181 [Accessed January 31, 2013]